Skip to main content

Table 1 Mannose-binding lectin 2 (MBL2) gene polymorphisms in patients with infrequent and frequent exacerbation

From: Mannose-binding lectin protein and its association to clinical outcomes in COPD: a longitudinal study

Single nucleotide polymorphisms

Infrequent exacerbation n (%)

Frequent exacerbation n (%)

p value

Promoter region

   

HL (−550 G > C; rs11003125)

  

0.03

C/C (L/L)

77 (50.0)

46 (37.4)

 

G/C (H/L)

57 (37.0)

48 (39.0)

 

G/G (H/H)

20 (13.0)

29 (23.6)

 

YX (−221 G > C; rs7096206)

  

0.64

G/G (Y/Y)

92 (59.7)

80 (65.0)

 

G/C (Y/X)

53 (34.4)

36 (29.3)

 

C/C (X/X)

9 (5.8)

7 (5.7)

 

Exon 1

   

PQ (+4 C > T; rs7095891)

  

0.65

C/C (P/P)

89 (57.8)

77 (62.6)

 

C/T (P/Q)

47 (30.5)

35 (28.5)

 

T/T (Q/Q)

18 (11.7)

11 (8.9)

 

A/D (+223 C > T; rs5030737)

  

0.03

A/A (C/C)

124 (91.9)

119 (83.8)

 

A/D (C/T)

12 (7.8)

21 (17.1)

 

D/D (T/T)

0 (0)

1 (0.8)

 

A/B (+230 G > A; rs1800450)

   

A/A (G/G)

129 (83.8)

106(86.2)

0.79

A/B (G/A)

23 (14.9)

15 (12.2)

 

B/B (A/A)

2 (1.3)

2 (1.6)

 

A/C (+239 G > A; rs1800451)

   

A/A (G/G)

146 (94.8)

119 (96.7)

0.27

A/C (G/C)

8 (5.2)

3 (2.4)

 

C/C (A/A)

0 (0)

1 (0.8)

 
  1. The distribution of each polymorphism in promoter and exon 1 region of MBL2 is shown in infrequent and frequent exacerbation. The HL and AD polymorphisms were significantly different between exacerbation groups. The rs number for each SNP represents the reference Single nucleotide polymorphisms identification number